Martingale Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-26,918
Closed -$752K 877
2022
Q4
$752K Sell
26,918
-51,728
-66% -$1.32M 0.01% 540
2022
Q3
$1.84M Buy
78,646
+30,524
+63% +$922K 0.04% 266
2022
Q2
$1.63M Buy
+48,122
New +$1.69M 0.03% 329
2021
Q3
Sell
-17,669
Closed -$535K 909
2021
Q2
$535K Buy
+17,669
New +$582K 0.01% 568

Other funds holding OGN

Martingale Asset Management's OGN Position: Q1 2023 in Review

Martingale Asset Management sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 26,918 shares — an estimated $752K sold.

Martingale Asset Management first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $1.84M in Q3 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Martingale Asset Management reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Martingale Asset Management sold 26,918 Organon & Co shares in Q1 2023, an estimated $752K.
  • Martingale Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Martingale Asset Management's Organon & Co position peaked at $1.84M in Q3 2022.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Martingale Asset Management's 13F filing for Q1 2023, filed 12 May 2023.